Elaine Adler

Dr. Adler brings extensive experience in drug development and evaluation. Prior to joining Israel Biotech Fund, Elaine worked as a Scientist, Project Leader and Team Leader responsible for non clinical pharmacology development at TEVA. Elaine holds a Ph.D. in Physiology from Monash University, Australia. Elaine completed her postdoctoral training in Neurobiology at the Weizmann Institute of Science under the supervision of Professor Alon Chen. In support of her work at the Weizmann Institute, Elaine received a National Network of Excellence fellowship from TEVA.